Tobacco Treatment in the Context of Lung Cancer Screening
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Smoking Cessation
- Sponsor
- Medical University of South Carolina
- Enrollment
- 48
- Locations
- 1
- Primary Endpoint
- End of Treatment Abstinence Rates
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The proposed study will test a medication plus text messaging intervention specifically designed for lung cancer screening patients. Half of the patients will receive standard of care, and half will receive the treatment intervention.
Detailed Description
Screening for lung cancer at earlier, more treatable stages has the potential to reduce mortality from the U.S.'s most deadly cancer. Annual lung cancer screening with low-dose computed tomography is now recommended for high risk individuals based on age and smoking history. This study will evaluate a smoking cessation intervention for lung cancer screening patients. We will evaluate quit rates after a standard intervention (brief counseling session at time of lung cancer screening) versus a dual nicotine replacement therapy (NRT) and gain-framed text messaging intervention.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
End of Treatment Abstinence Rates
Time Frame: Week 8 (end of treatment)
7-day point prevalence abstinence
Secondary Outcomes
- End of Study Abstinence Rates(3-month follow-up)